IL10 and infection: The absence of cerebral symptoms in the bpV(phen)-treated IL-10KO mice demonstrates that IL-10 is not required to preclude the development of neuropathology following PTP inhibition; however, the increased percentage of IL-10KO mice succumbing to the infection at early time points indicates that IL-10 has a key role in limiting P. berghei ANKA-induced pathology.